Ledger.Open graph →
SEC Form D · filed September 25, 2015

Corvus Pharmaceuticals, Inc

Offering
$75.0M
Sold
$75.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
BURLINGAME, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Peter P. Thompson · New York, NYDirectorAnders Ullberg · Stockholm, V7DirectorLeiv P. Lea · Burlingame, CAExecElisha (Terry) P. Gould · Chicago, ILDirectorPeter P. Moldt · Kellenup, NetherlandsDirectorRichard A. Miller · Portola Valley, CAExec · DirectorMikael Bergstedt · Stockholm, V7DirectorLeiv P. Lea · Burlingame, CAExecElisha (Terry) P. Gould · Chicago, ILDirectorPeter P. Moldt · Kellenup, NetherlandsDirectorRichard A. Miller · Portola Valley, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗